| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/29/2023 | -10.2% | Mizuho | → $22 | Downgrades | Neutral → Underperform |
| 08/03/2023 | -10.2% | RBC Capital | $21 → $22 | Maintains | Sector Perform |
| 05/03/2023 | -14.29% | RBC Capital | $23 → $21 | Maintains | Sector Perform |
| 03/07/2023 | -18.37% | JP Morgan | $17 → $20 | Maintains | Underweight |
| 02/15/2023 | -6.12% | RBC Capital | $19 → $23 | Maintains | Sector Perform |
| 02/15/2023 | -10.2% | Mizuho | $19 → $22 | Maintains | Neutral |
| 11/08/2022 | -22.45% | Mizuho | $18 → $19 | Maintains | Neutral |
| 07/27/2022 | -26.53% | Mizuho | → $18 | Initiates Coverage On | → Neutral |
| 05/04/2022 | -26.53% | RBC Capital | $17 → $18 | Maintains | Sector Perform |
| 03/14/2022 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 12/16/2021 | -38.78% | Wells Fargo | $13 → $15 | Maintains | Underweight |
| 08/06/2020 | -51.02% | Wells Fargo | $10 → $12 | Maintains | Underweight |
| 08/06/2020 | -46.94% | Stifel | $14 → $13 | Maintains | Hold |
| 07/22/2020 | -59.18% | Wells Fargo | $8 → $10 | Maintains | Underweight |
| 06/05/2020 | -30.61% | UBS | → $17 | Upgrades | Neutral → Buy |
| 05/06/2020 | -59.18% | JP Morgan | $12 → $10 | Maintains | Neutral |
| 04/24/2020 | -51.02% | JP Morgan | $17 → $12 | Downgrades | Overweight → Neutral |
| 04/14/2020 | -67.35% | Wells Fargo | $10 → $8 | Maintains | Underweight |
| 03/17/2020 | -42.86% | B. Riley Securities | $20 → $14 | Downgrades | Buy → Neutral |
| 03/10/2020 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 03/09/2020 | -30.61% | JP Morgan | $20 → $17 | Maintains | Overweight |
| 01/07/2020 | — | Wells Fargo | Downgrades | Equal-Weight → Underweight | |
| 11/07/2019 | -26.53% | Wells Fargo | $17 → $18 | Maintains | Market Perform |
| 10/17/2019 | -26.53% | Stifel | → $18 | Downgrades | Buy → Hold |
| 04/04/2019 | -26.53% | Stifel | → $18 | Initiates Coverage On | → Buy |
| 01/03/2019 | -48.98% | UBS | $17 → $12.5 | Downgrades | Buy → Neutral |
| 11/07/2018 | -14.29% | RBC Capital | → $21 | Upgrades | Sector Perform → Outperform |
What is the target price for USA Compression Partners (USAC)?
The latest price target for USA Compression Partners (NYSE: USAC) was reported by Mizuho on September 29, 2023. The analyst firm set a price target for $22.00 expecting USAC to fall to within 12 months (a possible -10.20% downside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for USA Compression Partners (USAC)?
The latest analyst rating for USA Compression Partners (NYSE: USAC) was provided by Mizuho, and USA Compression Partners downgraded their underperform rating.
When is the next analyst rating going to be posted or updated for USA Compression Partners (USAC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of USA Compression Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for USA Compression Partners was filed on September 29, 2023 so you should expect the next rating to be made available sometime around September 29, 2024.
Is the Analyst Rating USA Compression Partners (USAC) correct?
While ratings are subjective and will change, the latest USA Compression Partners (USAC) rating was a downgraded with a price target of $0.00 to $22.00. The current price USA Compression Partners (USAC) is trading at is $24.50, which is out of the analyst's predicted range.